HUTCHMED (China) (HCM) Non Operating Interest Expenses (2015 - 2016)
HUTCHMED (China)'s (HCM) quarterly Non Operating Interest Expenses came in at -$87000.0 in Q2 2016, down 191.58% year-on-year from $95000.0 in Q3 2015, and down 191.58% on a QoQ basis from $95000.0 in Q2 2015.
HUTCHMED (China) (HCM) Non Operating Interest Expenses (2015 - 2016) Analysis & Trends
HUTCHMED (China) (HCM) has 2 years of Non Operating Interest Expenses data on file, last reported at -$87000.0 in Q2 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | - |
| 10 | HUTCHMED (China) | 9.45 Bn | 9.45 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2016 | -87,000.00 |
| Jun 30, 2015 | 95,000.00 |